This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Sinovac Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $3.686. Sinovac Biotech's 10-Year median PS Ratio is 11.5084. Therefore, the Median PS Value for today is $42.42.
As of today (2024-04-25), Sinovac Biotech's share price is $6.47. Sinovac Biotech's Median PS Value is $42.42. Therefore, Sinovac Biotech's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Sinovac Biotech's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of Sinovac Biotech was 1.46. The lowest was 0.01. And the median was 0.79.
SVA's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.66 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Sinovac Biotech Median PS Value Historical Data
The historical data trend for Sinovac Biotech's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinovac Biotech's Median PS Value
For the Biotechnology subindustry, Sinovac Biotech's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinovac Biotech's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sinovac Biotech's Price-to-Median-PS-Value falls into.
Sinovac Biotech Median PS Value Calculation
Sinovac Biotech's Median PS Value for today is calculated as
10-Year Median PS Ratio is 11.5084.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinovac Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $3.686.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinovac Biotech (NAS:SVA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sinovac Biotech's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
6.47
/
42.42
=
0.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinovac Biotech Median PS Value Related Terms
Thank you for viewing the detailed overview of Sinovac Biotech's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinovac Biotech (Sinovac Biotech) Business Description
Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SVA has been successfully added to your 